September 2021
1. SCHELTENS P
   Responding to responsive behaviour in Alzheimer's disease - Author's reply.
   Lancet. 2021;398:842.
   

   >> Share

   
   
2. O'NEILL D, Kennelly S
   Responding to responsive behaviour in Alzheimer's disease.
   Lancet. 2021;398:842.
   

   >> Share

   
   July 2021
3. JAFFE S
   US FDA defends approval of Alzheimer's disease drug.
   Lancet. 2021;398:12.
   

   >> Share

   
   March 2021
4. SCHELTENS P, De Strooper B, Kivipelto M, Holstege H, et al
   Alzheimer's disease.
   Lancet. 2021 Mar 2. pii: S0140-6736(20)32205.
   

   >> Share

   
   February 2021
5. SIVA N
   New global initiative to tackle Alzheimer's disease.
   Lancet. 2021;397:568-569.
   

   >> Share

   
   June 2020
6. FORTEA J, Vilaplana E, Carmona-Iragui M, Benejam B, et al
   Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study.
   Lancet. 2020;395:1988-1997.
   

   >> Share

   
   
7. HEAD E, Ances B
   Biomarkers in Down syndrome can help us understand Alzheimer's disease.
   Lancet. 2020;395:1951-1953.
   

   >> Share

   
   February 2020
8. SEN A, Jette N, Husain M, Sander JW, et al
   Epilepsy in older people.
   Lancet. 2020;395:735-748.
   

   >> Share

   
   
9. WATTS G
   Giovanna Mallucci: redefining neurodegeneration.
   Lancet. 2020;395:486.
   

   >> Share

   
   September 2019
10. KEUSS SE, Bowen J, Schott JM
    Looking beyond the eyes: visual impairment in posterior cortical atrophy.
    Lancet. 2019;394:1055.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share